Home
About
Overview
Sharing Data
ORCID
Help
History (137)
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Circulating MicroRNA
Sundstrom, Beth
Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction.
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
See All 137 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy. Nat Med. 2018 02; 24(2):144-153.
View in:
PubMed
subject areas
Biomarkers
Humans
Immunotherapy
Melanoma
Programmed Cell Death 1 Receptor
Single-Cell Analysis
authors with profiles
Carsten Krieg
Silvia Guglietta